; and (ii) 20 percent ad valorem for those containing an active pharmaceutical ingredient from India. (d) Effective date The provisions of this section shall apply to articles described in subsections (a), (b), and (c) entered, or withdrawn from warehouse for consumption, on or after the date that is 15 days after the date of the enactment of this Act. 5. Secure Medicines Supply Fund (a) Establishment There is established in the Treasury of the United States a fund, to be known as the Secure Medicines Supply Fund (in this section referred to as the Fund ), consisting of such amounts as may be deposited to the Fund pursuant to subsection (b) to be used, in accordance with subsection (c), for the purpose of supporting and incentivizing pharmaceutical or device companies to invest in new pharmaceutical or device manufacturing capacity in the 50 States, the District of Columbia, Puerto Rico, the Virgin Islands, Guam, American Samoa, and the Commonwealth of the Northern Mariana Islands. (b) Requirements To be eligible for investment under subsection (a), new pharmaceutical or device manufacturing capacity shall meet each of the following: (1) The products supported by the new pharmaceutical or device manufacturing capacity do not use active pharmaceutical ingredients or parts manufactured in China or India. (2) At least 50 percent of the active pharmaceutical ingredients or parts for the total product line of the respective company is manufactured in any of the 50 States, the District of Columbia, Puerto Rico, the Virgin Islands, Guam, American Samoa, or the Commonwealth of the Northern Mariana Islands. (c) Funding (1) Duties Amounts collected from duties imposed pursuant to section 4 shall be deposited in the Fund, to remain available until expended. (2) Fines Amounts collected from civil monetary penalties imposed pursuant to paragraph (10) of section 303(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 333(f) ), as added by section 3(d), shall be deposited in the Fund, to remain available until expended.